Maria Hanl

Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells”.

Hydrazide-Based Class I Selective HDAC Inhibitors Completely Reverse Chemoresistance Synergistically in Platinum-Resistant Solid Cancer Cells

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01817

N/A

0.539DataRank · unranked

18 citations

Lukas Biermann, Linda Schäker-Hübner, Maria Hanl, Alexandra Hamacher, Matthias U. Kassack +3 more

Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c02569

N/A

0DataRank · unranked

14 citations

Irina Honin, Martina Miranda, Heiko B. Weber, Svenja Henze, Maria Hanl +2 more

Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c02373

N/A

0DataRank · unranked

13 citations

Lukas Biermann, P. R. Watson, Jingyu Li, Beate König, Matthew N. Gaynes +11 more